SFM
FOLD

Sphera Funds Management’s Amicus Therapeutics FOLD Stock Holding History

Sphera Funds Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-300,000
Closed -$2.54M – 100
2016
Q1 		$2.54M Buy
+300,000
New +$2.12M 0.55% 35

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Sphera Funds Management's FOLD Position: Q2 2026 in Review

Sphera Funds Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 603,377 shares — an estimated $8.72M sold.

Sphera Funds Management first reported a position in FOLD in Q4 2014 and held it in 30 quarters. The position peaked at $33.8M in Q1 2019. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Sphera Funds Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sphera Funds Management sold 603,377 Amicus Therapeutics shares in Q2 2026, an estimated $8.72M.
  • Sphera Funds Management first reported a position in Amicus Therapeutics in Q4 2014 and held it in 30 quarters.
  • Sphera Funds Management's Amicus Therapeutics position peaked at $33.8M in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.